Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) Price & Performance

GE HealthCare Technologies Inc. Common StockTrade
T-Rex 2X Inverse MSTR Daily Target ETFTrade

Price performance (Past 24H)

Key statistics

GE HealthCare Technologies Inc. Common Stock vs T-Rex 2X Inverse MSTR Daily Target ETF — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.5 (market cap $31.07B), while T-Rex 2X Inverse MSTR Daily Target ETF trades at $3.15 (market cap $88.87M). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 349.6× T-Rex 2X Inverse MSTR Daily Target ETF's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while T-Rex 2X Inverse MSTR Daily Target ETF pays none. Which is the better fit depends on your goals.

GEHCMSTZ
Market Cap
$31.07B$88.87M
Volume
3,443,02052,792,380
Sector
HealthLeveraged / Inverse
52-Week High
$88.16$27.92
52-Week Low
$59.48$2.29
Enterprise Value
$39.53B—
Dividend Yield
0.23%—
Typical Hold Time
—8 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GE HealthCare Technologies Inc. Common Stock

GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.

The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.

T-Rex 2X Inverse MSTR Daily Target ETF

MSTZ trades at $2.69 with minimal daily movement (+0.37%). Technical indicators show a bearish bias with moving averages signaling caution, while oscillators remain neutral. The stock lacks available fundamental data for key valuation and profitability metrics, creating uncertainty about its financial health. Recent ETF coverage highlights performance trends but provides limited company-specific insights.

The outlook remains uncertain due to missing financial data and bearish technical signals. Investment opportunity hinges on future earnings visibility and improved technical momentum. Key risks include lack of financial transparency and weak technical positioning that could pressure the stock toward support levels near $2.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GEHC

No sentiment data available yet.

MSTZ
32% Buy68% Sell
Avg holding period · 8 Days

About GE HealthCare Technologies Inc. Common Stock

GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.

Read more on GEHC →

About T-Rex 2X Inverse MSTR Daily Target ETF

MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.

Read more on MSTZ →